4.8 Article

Scintigraphic evaluation in rabbits of nasal drug delivery systems based on carbopol 971p® and carboxymethylcellulose

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 68, Issue 2, Pages 207-214

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S0168-3659(00)00258-3

Keywords

gamma scintigraphy; Tc-99m labeled colloidal albumin; apomorphine; nasal drug delivery; carbopol; carboxymethylcellulose; mucociliary clearance

Ask authors/readers for more resources

The residence time of apomorphine mucoadhesive preparations incorporating Tc-99m labeled colloidal albumin in rabbit nasal cavity was evaluated by gamma scintigraphy. This technique was used to compare the nasal clearance of preparations based either on Carbopol 971P(R) or lactose (control), each with and without apomorphine, or carboxymethylcellulose with apomorphine. The planar I-min images showed an excipient-dependent progressive migration of radioactivity with time from the nasal cavity to the stomach and intestine. Thirty minutes post insufflation, the percentages of the formulations cleared from the nasal cavity were 47% for lactose, 26% for lactose/apomorphine, 10% for Carbopol 971P(R), and 3% for both Carbopol 971P(R)/apomorphine and carboxymethylcellulose/apomorphine. Three hours post insufflation, the percentages of the formulations cleared from the nasal cavity were 70% for lactose, 58% for lactose/apomorphine, 24% for Carbopol 971P(R), 12% for Carbopol 971P(R)/apomorphine, and 27% for carboxymethylcellulose/apomorphine. Apomorphine inhibited nasal mucociliary clearance since migration of the radioactivity administered with apomorphine containing preparations was in all cases slower than that of the corresponding powder without apomorphine. The peak plasma concentration of apomorphine was attained while all the formulations were still within the nasal cavity. The use of mucoadhesive polymers such as Carbopol 971P(R) or carboxymethylcellulose in nasal dosage forms increases their residence time within the nasal cavity and provides the opportunity for sustained nasal drug delivery. (C) 2000 Elsevier Science B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available